Registration Opening Soon for BOS Events 2025!

Dates for BOS Events 2025 are confirmed as 11th and 12th June for BOS Basel 2025 and 25th and 26th November for BOS Manchester 2025. Please find further details outlining provisional floor plans and pricing options at the event links provided. Note that we plan to open for registrations on Monday 4th November at 09.00 GMT.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for digital events and resources, please look out for an announcement soon on this. We look forward to welcoming you and your colleagues to BOS Events! Please contact the Bio2Business team for further details.

Featured Company (BOS Basel 2024)

LAURUS SYNTHESIS PRIVATE LIMITED
• Providing end-to-end CDMO Services to Pharma (Human and Animal Health) and Crop Protection Industries
• Drug Substance Development in our R&D facility with more than 1000 scientists. Supported by latest lab scale process equipment and analytical instruments
• Drug Product Development integrating...
View profile

Featured Speaker (BOS Basel 2024)

Acquiring ADC Manufacturing Capacities and Capabilities: Insights from an Outsourcing Career

Dr Firelli Alonso, Founder / Consultant, ConsultFi Biologics, LLC

ABSTRACT: In the biopharmaceutical industry, a significant portion of companies increasingly depend on external partners for developing and producing biological drug substances and products for clinical trials and commercial distribution. The complexity deepens when dealing with Antibody Drug Conjugates (ADCs), as sourcing multiple components like monoclonal antibodies, linkers, payloads, and outsourcing the conjugation process
for drug substance production, as well as formulation and filling processes for drug product manufacture become essential. Moreover, the challenge escalates in identifying... Click here to Read More